IFNG and uterine cervix neoplasm: Microneedle administration of antibodies showed that the concentration of antibodies was 2 times higher than that of the control, and the T cells were more responsive to HPV-16 oncogenic antigen expressing cells (TC-1) (IFN-γ levels in control ≈ 250 pg/mL and ≈530 pg/mL. This enhanced immune response prevented the establishment of cervical tumors in 4 of the 9 mice treated with microneedles [92].